nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Procainamide—Sunitinib—pancreatic cancer	0.887	1	CrCrCtD
Sulfacetamide—Hepatic necrosis—Tamoxifen—pancreatic cancer	0.00475	0.0438	CcSEcCtD
Sulfacetamide—Blister—Tamoxifen—pancreatic cancer	0.00383	0.0353	CcSEcCtD
Sulfacetamide—Blister—Erlotinib—pancreatic cancer	0.00379	0.0349	CcSEcCtD
Sulfacetamide—Lupus erythematosus—Docetaxel—pancreatic cancer	0.00361	0.0333	CcSEcCtD
Sulfacetamide—Blister—Sunitinib—pancreatic cancer	0.00328	0.0302	CcSEcCtD
Sulfacetamide—Secondary infection—Epirubicin—pancreatic cancer	0.00309	0.0285	CcSEcCtD
Sulfacetamide—Secondary infection—Doxorubicin—pancreatic cancer	0.00286	0.0263	CcSEcCtD
Sulfacetamide—Blood disorder—Sunitinib—pancreatic cancer	0.00283	0.0261	CcSEcCtD
Sulfacetamide—Blister—Fluorouracil—pancreatic cancer	0.00259	0.0239	CcSEcCtD
Sulfacetamide—Systemic lupus erythematosus—Docetaxel—pancreatic cancer	0.00243	0.0224	CcSEcCtD
Sulfacetamide—Stinging—Fluorouracil—pancreatic cancer	0.0023	0.0212	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.0021	0.0193	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Erlotinib—pancreatic cancer	0.00207	0.0191	CcSEcCtD
Sulfacetamide—Acetaminophen—CNR1—pancreatic cancer	0.002	0.476	CrCbGaD
Sulfacetamide—Dermatitis bullous—Sunitinib—pancreatic cancer	0.0018	0.0166	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00179	0.0165	CcSEcCtD
Sulfacetamide—Gliclazide—VEGFA—pancreatic cancer	0.00159	0.379	CrCbGaD
Sulfacetamide—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00155	0.0142	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00153	0.0141	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00151	0.014	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00144	0.0133	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00142	0.0131	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00131	0.0121	CcSEcCtD
Sulfacetamide—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00131	0.0121	CcSEcCtD
Sulfacetamide—Erythema multiforme—Erlotinib—pancreatic cancer	0.0013	0.012	CcSEcCtD
Sulfacetamide—Blister—Epirubicin—pancreatic cancer	0.00126	0.0116	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00124	0.0114	CcSEcCtD
Sulfacetamide—Erythema—Tamoxifen—pancreatic cancer	0.00121	0.0111	CcSEcCtD
Sulfacetamide—Erythema—Erlotinib—pancreatic cancer	0.00119	0.011	CcSEcCtD
Sulfacetamide—Blister—Doxorubicin—pancreatic cancer	0.00117	0.0107	CcSEcCtD
Sulfacetamide—Erythema multiforme—Sunitinib—pancreatic cancer	0.00112	0.0103	CcSEcCtD
Sulfacetamide—Stinging—Epirubicin—pancreatic cancer	0.00112	0.0103	CcSEcCtD
Sulfacetamide—Blood disorder—Epirubicin—pancreatic cancer	0.00109	0.01	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00105	0.0097	CcSEcCtD
Sulfacetamide—Stinging—Doxorubicin—pancreatic cancer	0.00104	0.00956	CcSEcCtD
Sulfacetamide—Erythema—Sunitinib—pancreatic cancer	0.00103	0.00953	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00102	0.00942	CcSEcCtD
Sulfacetamide—Blood disorder—Doxorubicin—pancreatic cancer	0.00101	0.00927	CcSEcCtD
Sulfacetamide—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00099	0.00913	CcSEcCtD
Sulfacetamide—Oedema—Tamoxifen—pancreatic cancer	0.000985	0.00908	CcSEcCtD
Sulfacetamide—Infection—Tamoxifen—pancreatic cancer	0.000979	0.00902	CcSEcCtD
Sulfacetamide—Oedema—Erlotinib—pancreatic cancer	0.000975	0.00898	CcSEcCtD
Sulfacetamide—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000974	0.00898	CcSEcCtD
Sulfacetamide—Infection—Erlotinib—pancreatic cancer	0.000968	0.00892	CcSEcCtD
Sulfacetamide—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000901	0.0083	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00088	0.00811	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000853	0.00786	CcSEcCtD
Sulfacetamide—Oedema—Sunitinib—pancreatic cancer	0.000844	0.00777	CcSEcCtD
Sulfacetamide—Pain—Tamoxifen—pancreatic cancer	0.000842	0.00776	CcSEcCtD
Sulfacetamide—Infection—Sunitinib—pancreatic cancer	0.000838	0.00772	CcSEcCtD
Sulfacetamide—Pain—Erlotinib—pancreatic cancer	0.000833	0.00768	CcSEcCtD
Sulfacetamide—Erythema—Gemcitabine—pancreatic cancer	0.000829	0.00764	CcSEcCtD
Sulfacetamide—Erythema—Fluorouracil—pancreatic cancer	0.000816	0.00752	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000789	0.00727	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000747	0.00688	CcSEcCtD
Sulfacetamide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000726	0.00669	CcSEcCtD
Sulfacetamide—Pain—Sunitinib—pancreatic cancer	0.000721	0.00665	CcSEcCtD
Sulfacetamide—Agranulocytosis—Docetaxel—pancreatic cancer	0.000703	0.00648	CcSEcCtD
Sulfacetamide—Pruritus—Tamoxifen—pancreatic cancer	0.000697	0.00642	CcSEcCtD
Sulfacetamide—Oedema—Irinotecan—pancreatic cancer	0.000695	0.0064	CcSEcCtD
Sulfacetamide—Infection—Irinotecan—pancreatic cancer	0.00069	0.00636	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00069	0.00636	CcSEcCtD
Sulfacetamide—Pruritus—Erlotinib—pancreatic cancer	0.000689	0.00635	CcSEcCtD
Sulfacetamide—Oedema—Gemcitabine—pancreatic cancer	0.000677	0.00624	CcSEcCtD
Sulfacetamide—Infection—Gemcitabine—pancreatic cancer	0.000673	0.0062	CcSEcCtD
Sulfacetamide—Oedema—Fluorouracil—pancreatic cancer	0.000666	0.00613	CcSEcCtD
Sulfacetamide—Infection—Fluorouracil—pancreatic cancer	0.000661	0.00609	CcSEcCtD
Sulfacetamide—Erythema multiforme—Docetaxel—pancreatic cancer	0.000639	0.00589	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000638	0.00588	CcSEcCtD
Sulfacetamide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000622	0.00573	CcSEcCtD
Sulfacetamide—Pruritus—Sunitinib—pancreatic cancer	0.000597	0.0055	CcSEcCtD
Sulfacetamide—Pain—Irinotecan—pancreatic cancer	0.000594	0.00548	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000594	0.00547	CcSEcCtD
Sulfacetamide—Erythema—Docetaxel—pancreatic cancer	0.000589	0.00542	CcSEcCtD
Sulfacetamide—Pain—Gemcitabine—pancreatic cancer	0.000579	0.00533	CcSEcCtD
Sulfacetamide—Pain—Fluorouracil—pancreatic cancer	0.000569	0.00525	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000549	0.00506	CcSEcCtD
Sulfacetamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000512	0.00472	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000504	0.00464	CcSEcCtD
Sulfacetamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00049	0.00452	CcSEcCtD
Sulfacetamide—Oedema—Docetaxel—pancreatic cancer	0.00048	0.00443	CcSEcCtD
Sulfacetamide—Pruritus—Gemcitabine—pancreatic cancer	0.000479	0.00441	CcSEcCtD
Sulfacetamide—Infection—Docetaxel—pancreatic cancer	0.000477	0.0044	CcSEcCtD
Sulfacetamide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000474	0.00437	CcSEcCtD
Sulfacetamide—Pruritus—Fluorouracil—pancreatic cancer	0.000471	0.00434	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000466	0.00429	CcSEcCtD
Sulfacetamide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000439	0.00404	CcSEcCtD
Sulfacetamide—Erythema multiforme—Epirubicin—pancreatic cancer	0.000431	0.00397	CcSEcCtD
Sulfacetamide—Pain—Docetaxel—pancreatic cancer	0.000411	0.00379	CcSEcCtD
Sulfacetamide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000399	0.00368	CcSEcCtD
Sulfacetamide—Erythema—Epirubicin—pancreatic cancer	0.000397	0.00366	CcSEcCtD
Sulfacetamide—Acetaminophen—PTGS2—pancreatic cancer	0.000369	0.088	CrCbGaD
Sulfacetamide—Erythema—Doxorubicin—pancreatic cancer	0.000367	0.00339	CcSEcCtD
Sulfacetamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000354	0.00326	CcSEcCtD
Sulfacetamide—Pruritus—Docetaxel—pancreatic cancer	0.00034	0.00313	CcSEcCtD
Sulfacetamide—Oedema—Epirubicin—pancreatic cancer	0.000324	0.00299	CcSEcCtD
Sulfacetamide—Infection—Epirubicin—pancreatic cancer	0.000322	0.00297	CcSEcCtD
Sulfacetamide—Oedema—Doxorubicin—pancreatic cancer	0.0003	0.00276	CcSEcCtD
Sulfacetamide—Infection—Doxorubicin—pancreatic cancer	0.000298	0.00274	CcSEcCtD
Sulfacetamide—Pain—Epirubicin—pancreatic cancer	0.000277	0.00255	CcSEcCtD
Sulfacetamide—Pain—Doxorubicin—pancreatic cancer	0.000256	0.00236	CcSEcCtD
Sulfacetamide—Dapsone—PTGS2—pancreatic cancer	0.000241	0.0576	CrCbGaD
Sulfacetamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000239	0.0022	CcSEcCtD
Sulfacetamide—Pruritus—Epirubicin—pancreatic cancer	0.000229	0.00211	CcSEcCtD
Sulfacetamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000221	0.00204	CcSEcCtD
Sulfacetamide—Pruritus—Doxorubicin—pancreatic cancer	0.000212	0.00195	CcSEcCtD
